Compound Detail
CHEMBL3717195
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc(OCc2csc(-c3ccc(C(C)(C)O)cc3)n2)c2cc(-c3cn4nc(OC)sc4n3)oc2c1
Basic Information
| ChEMBL ID | CHEMBL3717195 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WILKSHHHRGQDLY-UHFFFAOYSA-N |
2
Targets
5
Activities
2
Assay Types
4
PK Parameters
4
Publications
0
Known Names
Molecular Properties
548.6
MW (Da)
6.15
ALogP
11
HBA
1
HBD
104.1
PSA (Ų)
0.24
QED
3
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 3 meas. best 8.6
IC50 2 meas. best 8.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Proteinase-activated receptor 4 CHEMBL4691 | IC50 | 8.62 | 8.62 | 2.4 | 1 |
| Proteinase-activated receptor 4 CHEMBL4691 | EC50 | 8.6 | 8.6 | 2.5 | 3 |
| Plasma CHEMBL613424 | IC50 | 8.24 | 8.24 | 5.7 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 504.76 | ng.hr.mL-1 | Rattus norvegicus |
| T1/2 | 1.833 | hr | Homo sapiens |
| T1/2 | 1.15 | hr | Rattus norvegicus |
| t1/2 | - | - | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Proteinase-activated receptor 4 | IC50 | = | 2.4 | nM | 8.62 | Antagonist activity at full length human PAR4 expressed in HEK293 cells assessed... | 35729784 |
| Proteinase-activated receptor 4 | EC50 | = | 2.5 | nM | 8.6 | Antagonist activity against human PAR4 expressed in HEK293 cells assessed as red... | - |
| Proteinase-activated receptor 4 | EC50 | = | 2.5 | nM | 8.6 | FLIPR Assay: Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. ... | - |
| Proteinase-activated receptor 4 | EC50 | = | 2.5 | nM | 8.6 | PAR4 FLIPR assay: The activity of the PAR4 antagonists of the present invention ... | - |
| Plasma | IC50 | = | 5.7 | nM | 8.24 | Antiplatelet activity in human platelet-rich plasma assessed as inhibition of ga... | 35729784 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35729784 | 10.1021/acs.jmedchem.2c00359 | ADMET | 5 |
| 35729784 | 10.1021/acs.jmedchem.2c00359 | Proteinase-activated receptor 4 | 1 |
| 35729784 | 10.1021/acs.jmedchem.2c00359 | Plasma | 1 |
| 35729784 | 10.1021/acs.jmedchem.2c00359 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine